Synbiotic German cannabis group Synbiotic published an update on its eclectic portfolio of businesses this week, seeing sales rise
STENOCARE A/S (Stenocare) and ADREXpharma are now ready to deliver a new and innovative medical cannabis oil product for German
STENOCARE A/S (“Stenocare”), one of Europe’s Leading Medical Cannabis pharma companies is expanding into Canada together with North American Industry
Danish medical cannabis manufacturer Stenocare has launched a new ‘next generation’ cannabis oil, which it hopes will represent the ‘next
Voyager Life & Northern Leaf Aquis Stock Exchange-listed CBD company Voyager Life has announced plans for a merger with Jersey-based
Ananda Developments Ananda Developments has seen its stock increase over 5% this week after signing a ‘Drug Supply Agreement’ (DSA)
2024 is set to be the year of elections, with more than half of the global population (4.2m people) set
Jazz Pharmaceuticals Epidiolex (Epidyolex in the EU and UK), Jazz Pharmaceuticals’ market leading cannabis-based medication, has received authorisation to
Celadon Pharmaceuticals This morning (November 16), AIM-listed medical cannabis operator Celadon Pharmaceuticals announced that it has signed a
MGC Pharmaceuticals MGC Pharmaceuticals announced this week that it has now secured ‘binding commitments’ for US$7.9m in investment, which
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
